DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.
Firms / B•••••••• M••••••••• C••••••• L••
B•••••••• M••••••••• C••••••• L••
B•••••••• Capital is a for-profit venture firm investing in transformational data enabled innovation at the intersection of health care and technology.
venture manager, reported GAV $449M across 2 vehicles
Importance
21
moderate
Active deployment
0
low
Emerging
0
low
Completeness
63
high
Freshness
98
high
Research priority
4
low
Identity and regulatory footprint
- Headquarters
- Seattle, WAadviserinfo.sec.gov
- Office address
- 188 E BLAINE STREET, SUITE 126, Seattle, WA, 98102adviserinfo.sec.gov
- Business phone
- 206-719-6382adviserinfo.sec.gov
- Website
- b•••••••••.com
- SEC adviser type
- exempt reporting adviseradviserinfo.sec.gov
- SEC exemption claimed
- venture capital fund adviseradviserinfo.sec.govItem 2.B(1): advises solely venture capital funds
- Latest Form ADV
- Mar 27, 2026
- Private funds reported
- 1 (1 venture capital funds)adviserinfo.sec.gov
- Private fund gross assets
- $141Madviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
- business email
- info@biomaticscapital.combiomaticscapital.compublished by the subject
- business phone
- 206-240-3943adviserinfo.sec.govpublished by the subject
- business phone
- 206-719-6382adviserinfo.sec.govpublished by the subject
Stated thesis versus observed behaviour
no observed deals yet
Stated (the firm’s website)
- Sectors
- healthcare, biotech, medtech
- Stages
- not stated or not yet read
- Geography
- not stated
- Check size
- not stated; DFX does not estimate checks from round sizes
Observed (from deals on record)
Stage at participation: no observed deals yet
Stage at first entry: no observed deals yet
Sectors: no observed deals yet
lead rate n/afollow-on rate n/anew logos, 12 months 0
Funds and vehicles
2 reported
| Vehicle | Type | Vintage | Lifecycle | Reported GAV | Owners | Form D sold | Latest Form D |
|---|---|---|---|---|---|---|---|
| B•••••••• C•••••• P••••••• I•• L•• | Fund | 2019 adv first reported | Mature | $68.0M May 14, 2024 | 64 | $0 of $300M | May 17, 2018 |
| B•••••••• C•••••• P•••••••• L••• | Fund | 2016 form d first sale | Harvest | $381M May 14, 2024 | 41 | $200M of $200M | Nov 17, 2016 |
GAV is the gross asset value the adviser reported on Form ADV for the vehicle, never the fund’s committed size and never dry powder. Form D sold is the amount sold as of the latest filing, never a final close.
Investment team
2 current, 0 departed
B•••• N••••••
PartnerMember · since Apr 1, 2016
J•••• E•••••• S•••••••••
PartnerMember · since Apr 1, 2016
Investments on record
0 edges, 0 companies, 0 partner-attributed
No investment on record yet. Edges arrive from the firm’s portfolio page, financing announcements, and Form D board seats.
Co-investors
0 relationships from shared deals, counted for the whole firm
No co-investor relationship yet: these are derived only from rounds and portfolio listings the graph has seen both investors on.
Limited partners
0 disclosed
No LP commitment on record. An LP edge needs a public disclosure with a quote: a pension report (see Limited partners for the plans read), a fund announcement naming the LP, or a Form ADV owner. The fund page carries the LP’s reported performance.
Timeline
3 dated events
- Apr 10, 2019B•••••••• C•••••• P••••••• I•• L•• first reported on Form ADV by B•••••••• M••••••••• C••••••• L•• (Venture Capital Fund), GAV $7,403,904Fund first reported on Form ADVFundsFactB•••••••• C•••••• P••••••• I•• L••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Aug 25, 2016B•••••••• M••••••••• C••••••• L•• first filed Form ADV (ERA, venture capital fund adviser exemption)First SEC adviser filingOrganizationFactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Aug 25, 2016B•••••••• C•••••• P•••••••• L••• first reported on Form ADV by B•••••••• M••••••••• C••••••• L•• (Venture Capital Fund), GAV $105,000,000Fund first reported on Form ADVFundsFactB•••••••• C•••••• P•••••••• L•••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Classification history
- Sep 12, 2026Institutional venture firm (confirmed, 95%, cls-1)venture manager, reported GAV $449M across 2 vehicles
Evidence
47 observations from 3 sources